Skip to main content

Table 3 Analysis of MIDAS and HIT score in a different group (A: Sodium Valproate; B: Sodium Valproate +Magnesium; C: Magnesium) compared to baseline

From: Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial

  A P-value B P-value C P-value
Pre-intervention Post-intervention   Pre-intervention Post-intervention   Pre-intervention Post-intervention  
MIDAS 21.74 ± 4.44 17.11 ± 4.06 < 0.001 21.68 ± 3.72 16.11 ± 3.87 < 0.001 22.13 ± 1.88 18.81 ± 1.76 < 0.001
HIT-6 56.72 ± 4.59 49.91 ± 4.58 < 0.001 56.89 ± 3.84 50.50 ± 3.27 < 0.001 57.54 ± 2.13 53.03 ± 1.88 < 0.001
  1. MIDAS migraine disability assessment score; HIT-6 Headache Impact Test-6 score